Meiju Ji

Highly Prevalent Genetic Alterations in Receptor Tyrosine Kinases and Phosphatidylinositol 3-Kinase/Akt and Mitogen-Activated Protein Kinase Pathways in Anaplastic and Follicular Thyroid Cancers

Zhi Liu, Peng Hou, Meiju Ji et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 389 citations

Medicine, Genetics, Oncology +17

<i>BRAF</i> Mutation Testing of Thyroid Fine-Needle Aspiration Biopsy Specimens for Preoperative Risk Stratification in Papillary Thyroid Cancer

Mingzhao Xing, Douglas P. Clark, Haixia Guan et al. · Journal of Clinical Oncology · 2009 · 255 citations · Full text

Medicine, Molecular Genetics, Oncology +16

Vitamin C kills thyroid cancer cells through ROS-dependent inhibition of MAPK/ERK and PI3K/AKT pathways via distinct mechanisms

Xi Su, Zhen Shen, Qi Yang et al. · Theranostics · 2019 · 247 citations · Full text

Medicine, Oncology, Pharmacology +15

Association of High Iodine Intake with the T1799A BRAF Mutation in Papillary Thyroid Cancer

Haixia Guan, Meiju Ji, Rong Bao et al. · The Journal of Clinical Endocrinology & Metabolism · 2009 · 223 citations · Full text

Medicine, Genetics, Molecular Genetics +16

High Prevalence and Mutual Exclusivity of Genetic Alterations in the Phosphatidylinositol-3-Kinase/Akt Pathway in Thyroid Tumors

Yangang Wang, Peng Hou, Hongyu Yu et al. · The Journal of Clinical Endocrinology & Metabolism · 2007 · 174 citations

Medicine, Genetics, Molecular Genetics +17